Add BrightSurf on Google Email

Search results for “Endocrinology”

1,000+ results for "Endocrinology"

Irregular periods in young women could be warning sign for later osteoporosis

Women with irregular periods are at increased risk of developing osteoporosis later in life, according to a recent study. The research found that nearly all women with premature ovarian failure reported changes in their menstrual cycle, highlighting the importance of early evaluation and treatment.

Insulin pump effective for infants, children

A recent study by Duke University Medical Center researchers found that toddlers and preschool children with Type I diabetes can successfully use insulin pumps with proper supervision. The study involved nine children who were treated with insulin pumps for seven to 19 months, resulting in improved blood glucose control and a significa...

Scientists discover gene in human egg that may be necessary for female fertility

Researchers have identified a human gene that appears to be the counterpart to the mouse Mater gene, essential for fertilized egg development. The discovery may lead to new approaches in studying and treating female infertility, as well as understanding the role of the immune system in premature ovarian failure.

Mayo Clinic news briefs

A Mayo Clinic study finds an association between estrogen status and reduced coronary calcium and plaque area, suggesting a potential benefit against heart disease. Estrogen may modulate the calcium content of atherosclerotic plaques, slowing progression of atherosclerosis in women.

SourceMayo Clinic·JournalJournal of Endocrinology and Metabolism·DateMar 13, 2002

Oral diabetes drug shows promise in preventing miscarriage in common infertility disorder

A study suggests that metformin, an oral diabetes drug, reduces the risk of miscarriage in women with Polycystic Ovary Syndrome (PCOS). Researchers found that 8.8% of pregnancies treated with metformin ended in miscarriage, compared to 41.9% in those not receiving the medication.

SourceNIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development·JournalThe Journal of Clinical Endocrinology & Metabolism·DateFeb 27, 2002

Sharp drop in stress hormones may set stage for arthritis, multiple sclerosis after pregnancy

Researchers found that levels of IL-12 and TNF alpha decreased during pregnancy, while cortisol, norepinephrine, and 1,25 hydroxyvitamin D3 increased. After birth, these stress hormones surged, possibly contributing to the resurgence of immune disorders like rheumatoid arthritis and multiple sclerosis.

SourceNIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development·JournalThe Journal of Clinical Endocrinology & Metabolism·DateOct 30, 2001

In first human trial, insulin shows ability to reduce components that inflame vessel walls

A new study by University at Buffalo researchers found that insulin can reduce pro-inflammatory components in the bloodstream while increasing anti-inflammatory components. The results suggest that insulin may have anti-atherosclerotic effects and potentially reduce the risk of heart attack, contrary to previous assumptions.

SourceUniversity at Buffalo·JournalThe Journal of Clinical Endocrinology & Metabolism·DateAug 8, 2001

Hopkins Children's Center researchers find cause for common kind of dwarfism

Researchers at Johns Hopkins Children's Center found a faulty releasing hormone receptor gene in three families with isolated growth hormone deficiency type 1-B, the most common type of growth hormone-deficient dwarfism. The study suggests that this condition is not caused by a defect in human growth hormone production.

SourceJohns Hopkins Medicine·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJan 10, 2001

Low dose estrogen improves bone health

A low dose of estrogen was as effective as a higher dose in reducing bone turnover and preventing osteoporosis in older women. The study found that women taking 0.25 mg estradiol had no more side effects than those taking a placebo, improving bone health with fewer risks.

SourceNIH/National Institute on Aging·JournalThe Journal of Clinical Endocrinology & Metabolism·DateDec 3, 2000

Growth hormone may shorten life span, study finds

A recent study published in Endocrinology found that mice engineered without the receptor for growth hormone lived almost one year longer than normal mice, suggesting that the natural hormone may actually shorten lifespan. The researchers are now searching for genes regulated by growth hormone that might play a specific role in life span.

SourceOhio University·JournalEndocrinology·DateOct 18, 2000

Study Shows Glucose Consumption Increases Production of Destructive Free Radicals, Lowers Level of Key Antioxidant

A study published in The Journal of Clinical Endocrinology and Metabolism found that excess glucose consumption stimulates the generation of free radicals, which can damage cells lining blood vessels. The researchers also observed a decrease in levels of a-tocopherol, a powerful antioxidant.

SourceUniversity at Buffalo·JournalThe Journal of Clinical Endocrinology & Metabolism·DateAug 15, 2000

Link found between AIDS medications and diabetes

Researchers link HIV-protease inhibitors to increased diabetes risk due to impaired glucose storage, prompting reevaluation of screening methods and development of new treatments. Up to 83% of patients on the drugs develop excess belly fat and type 2 diabetes.

SourceWashU Medicine·JournalJournal of Biological Chemistry·DateMay 16, 2000

Menstrual function develops more rapidly than previously thought

New research reveals that menstrual function matures rapidly after the first period, accompanied by a surge in hormones, rather than gradually over four to six years as previously thought. This finding has significant implications for adolescent pregnancy prevention and contraception initiation.

SourcePenn State·JournalThe Journal of Clinical Endocrinology & Metabolism·DateApr 13, 2000

University of Pittsburgh research may lead to new therapies for diabetes

Researchers at the University of Pittsburgh have developed transgenic mice that overexpress hepatocyte growth factor, leading to increased beta cell proliferation and insulin production. The study suggests that this approach may lead to new therapies for diabetes by enabling islet cells to proliferate and produce insulin more effectively.

SourceUniversity of Pittsburgh Medical Center·JournalJournal of Biological Chemistry·DateJan 14, 2000